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Abstract 
Background: A novel strategy applying an organophosphate‑based insecticide paint on doors and windows in com‑
bination with long‑lasting insecticide‑treated nets (LLINs) was tested for the control of pyrethroid‑resistant malaria 
vectors in a village setting in Vallée du Kou, a rice‑growing area west of Burkina Faso.
Methods: Insecticide Paint Inesfly 5A IGR™, comprised of two organophosphates and an insect growth regulator, 
was applied to doors and windows and tested in combination with pyrethroid‑treated LLINs. The killing effect was 
monitored for 5 months by early morning collections of anophelines and other culicids. The residual efficacy was 
evaluated monthly by WHO bioassays using Anopheles gambiae ‘Kisumu’ and local populations of Anopheles coluzzii 
resistant to pyrethroids. The spatial mortality efficacy (SME) at distances of 1 m was also assessed against pyrethroid‑
susceptible and ‑resistant malaria vectors. The frequency of L1014F kdr and Ace‑1R G119S mutations was, respec‑
tively, reported throughout the study. The Insecticide Paint Inesfly 5A IGR had been tested in past studies yielding a 
long‑term mortality rate of 80% over 12 months against An. coluzzii, the local pyrethroid‑resistant malaria vector. The 
purpose of the present study is to test if treating smaller, targeted surfaces (e.g. doors and windows) was also efficient 
in killing malaria vectors.
Results: Treating windows and doors alone yielded a killing efficacy of 100% for 1 month against An. coluzzii resistant 
to pyrethroids, but efficacy reduced quickly afterwards. Likewise, WHO cone bioassays yielded mortalities of 80–100% 
for 2 months but declined to 90 and 40% 2 and 3 months after treatment, respectively. Mosquitoes exposed to insec‑
ticide paint‑treated surfaces at distances of 1 m, yielded mortality rates of about 90–80% against local pyrethroids‑
resistant An. coluzzii during the first 2 months, but decreased to 30% afterwards. Anopheles coluzzii was reported to be 
exclusively the local malaria vector and resistant to pyrethroids with high L1014 kdr frequency.
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Background
Malaria affects millions of people worldwide, especially 
in Africa. According to the latest official estimates, in 
2016, there were 216 million cases of malaria worldwide 
compared to 237 million cases in 2010 and 211 million 
new cases in 2015; there were about 445,000 deaths from 
malaria globally, compared to 446,000 malaria deaths 
in 2015. Most of these deaths occurred in the African 
region (91%), followed by the Southeast Asian region 
(6%) and the Eastern Mediterranean region (2%). Chil-
dren are especially vulnerable, accounting for more than 
two-thirds of global malaria deaths [1].
Because of the burden that malaria continues to repre-
sent, there has been a scale-up of malaria control strate-
gies in the last 15 years. There are three main strategies: 
(i) vector control is mainly based on the use of insecti-
cide-treated mosquito nets (ITNs)/long-lasting insecti-
cide-treated nets (LLINs) and indoor residual spraying 
(IRS). The only class of insecticides approved for treat-
ing ITNs and LLINs are pyrethroids. IRS interventions 
are also mostly based on pyrethroid use, but some use 
dichlorodiphenyltrichloroethane (DDT) and, to a lesser 
extent, organophosphates (OPs) and carbamates; (ii) 
chemoprevention: prevention campaigns are mostly tar-
geted at groups at risk, such as pregnant women and, 
more recently, children in areas where transmission is 
seasonal; (iii) case management: based on prompt diag-
nosis (such as the use of rapid diagnostic tests) and 
resistance management, based on artemisinin-based 
combination therapy (ACT).
Of these three strategies, the one showing greatest 
impact in reducing clinical cases of malaria in Africa 
is vector control and the use of ITNs and LLINs [2, 3]. 
Progress is being made, but the burden of malaria is still 
large, especially in Africa. The spread of resistance to 
pyrethroids due to the kdr mechanism could potentially 
hamper further progress [4–6]. There is no consensus on 
whether this resistance translates into reduced efficacy 
of malaria control programmes but there is a risk that it 
could [7–10]. In addition, both IRS [11] and ITNs/LLINs 
[12, 13] are not always accepted well by populations and/
or they are used incorrectly. Because of the potential 
problems that widespread resistance to pyrethroids may 
pose and because of operational obstacles, there is a need 
for new tools against malaria vectors [14–16].
The present work studies the efficacy of an insecticide 
paint, Inesfly 5A IGR™, consisting of a microencapsu-
lated formulation of two OPs, chlorpyrifos and diazinon, 
and an insect growth regulator (IGR), pyriproxyfen, all 
contained in a white vinyl paint with an aqueous base. 
Both OPs and pyriproxyfen have a different mode of 
action than pyrethroids, which may address the issue of 
resistance.
The paint may present advantages, compared to IRS, 
as its application does not require special equipment or 
trained personnel, and could lead to home improvement. 
Toxicology studies were performed on this product and 
proved its safety in terms of irritancy (ocular, dermal, sys-
temic), cytotoxicity, mutagenicity, and allergenicity [17, 
18]. It has been evaluated over a series of studies with 
promising results [19–22]. In particular, the latest study, 
the pilot pre-phase III in the VK1 village from Vallée du 
Kou, Burkina Faso, where the inner walls of houses were 
treated with the insecticide paint, in combination with 
LLINs [22]. Given these positive results, the present 
study was carried at VK3 village, also in Vallée du Kou. 
The objective of the present study is to test if treating a 
smaller surface (unlike the study carried at VK1), tar-
geted at entry points of houses, offers protection in terms 
of mosquito mortality.
Methods
Study site
The study was conducted in VK3 village in the Kou Val-
ley (11° 23′ 14″N; 4° 24′ 42″W), a rice-growing area of 
southwestern Burkina Faso, located 30  km north of 
Bobo-Dioulasso (Fig.  1). Malaria vectors in the area are 
abundant throughout the year and the frequency of the 
L1014F kdr mutation is high, inducing high resistance 
levels of local malaria vectors populations to pyrethroids 
and DDT [23, 24]. Anopheles coluzzii (former Anopheles 
gambiae form M) was the only An. gambiae sensu lato 
(s.l.) species present in the area during the study, from 
August to December 2013, confirming previous results 
Conclusion: The combination of insecticide paint on doors and windows with LLINs yielded high mortality rates in 
the short term against wild pyrethroid‑resistant malaria vector populations. A high SME was observed against labora‑
tory strains of pyrethroid‑resistant malaria vectors placed for 30 min at 1 m from the treated/control walls. The applica‑
tion of the insecticide paint on doors and windows led to high but short‑lasting mortality rates. The strategy may be 
an option in a context where low cost, rapid responses need to be implemented in areas where malaria vectors are 
resistant to pyrethroids.
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obtained in VK3 village during the same season. The 
identification of Anopheles species among the An. gam-
biae complex was performed using a short interspersed 
nuclear elements (SINE)-PCR approach [25].
Insecticide paint and LLINs
Inesfly 5A IGR was applied on metallic doors and win-
dows of selected houses. It was applied on two sides of 
doors and windows with one layer of 1  kg commercial 
product/6 sq m (i.e., 166.67  g/sq m). Twenty inhabited 
houses were selected in the village and treated with the 
insecticide paint. In order to assess the effectiveness 
of the paint + LLIN combination, each occupant of 10 
treated homes received a new LLIN. These LLINs were 
used daily under supervision during the all survey. LLINs 
used during this study were new intact PermaNet 2.0, 
made of polyester netting impregnated with deltame-
thrin in a wash-resistant binder system (distributed by 
the National Malaria Control Programme in 2013). Ten 
control houses were selected and included in the study. 
The control houses were free of insecticide paint and 
new LLINs but sleepers could use any tool of their choice 
to protect themselves from nuisance. The 30 houses 
included in the study were selected according to their 
similarities in terms of size (the mean was 3.5 × 5 m), a 
distance of at least 20 m apart, with the informed consent 
of home owners. Houses were randomly allocated to the 
three arms: control, paint alone or paint + LLIN.
Early morning collections (EMCs)
Before randomizing the treatment arms, mosquito col-
lections took place for 1 full week in the 30 houses 
included in the study to ensure that there was no differ-
ence between houses in attractiveness to mosquitoes. 
One week after the treatment, mosquito collections were 
performed monthly over 4 consecutive days, between 
August and December 2013 (T0–T4).
Thirty volunteers from residents at VK3 of at least 
18  years old were recruited for the collections. After 
being informed about the study, the volunteers pro-
vided written informed consent (with a fingerprint if 
illiterate), and received training on mosquito collection 
procedures. Mosquito collections were performed fol-
lowing World Health Organization Pesticide Evaluation 
Scheme (WHOPES) testing procedures [26] for mortality 
rates, except that inhabited houses were used rather than 
experimental huts. Volunteers would enter the houses 
at 18:00  h, one volunteer per house, and sleep under 
Fig. 1 Location of VK3 at Vallée de Kou
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LLINs until 05:30 h. Before entering houses every even-
ing, houses would be cleaned to eliminate scavengers 
(i.e., ants and other insects that might be interested in 
dead mosquitoes). Volunteers rotated houses each night 
to avoid bias in mosquito collections. At the first suspi-
cion of malaria, volunteers were provided with curative 
treatment recommended by the National Malaria Con-
trol Programme in Burkina Faso. The study was approved 
by the Ethics Committee of the Institut de Recherche en 
Sciences de la Santé (IRSS)/Centre Muraz. Early in the 
morning, mosquito females were collected inside each 
house and classified as dead or alive, unfed or blood-fed. 
Live mosquitoes were observed for delayed mortality 
assessment after 24 h at 80 ± 10% relative humidity and 
27 ± 2  °C temperature. All mosquitoes were then con-
served in silica gel at − 20  °C to study the species and 
resistance status.
The design allowed the reliable assessment of the killing 
effect, deterrent effect and long-term residual efficacy of 
the treatment. Since the study was performed under real 
field conditions, the status (unfed or blood-fed) of female 
mosquitoes that entered the houses was not known, 
making it difficult to evaluate reliably the blood-feeding 
inhibition. Blood-feeding inhibition is generally assessed 
in experimental huts following Phase II WHOPES pro-
tocols, where the experimental design is well adapted to 
estimate this parameter.
Residual efficacy tests using 30‑min WHO bioassays
The World Health Organization (WHO) protocol for 
evaluation of residual efficacy was followed [27] using 
2–3  days old unfed females of An. gambiae ‘Kisumu’, a 
reference strain susceptible to all insecticides reared at 
the IRSS/Centre Muraz insectarium. The local malaria 
vector population at VK3, identified molecularly as An. 
coluzzii and resistant to pyrethroids, was reared at the 
insectarium from field-collected larvae to the adult stage; 
it was also tested in parallel to An. gambiae ‘Kisumu’.
For each house, 10 females were introduced in 5 cones 
placed on two sides of the paint-treated surface (or con-
trol) for 30 min on metallic doors and windows, respec-
tively. Cones were not placed on LLINs. Females were 
taken to the insectarium for delayed mortality assessment 
after 24  h at 80 ± 10% relative humidity and 27 ± 2  °C 
temperature. Tests were performed monthly from T0 to 
T4 after treatment.
Spatial mortality assessments
The effect of mortality was also assessed at a distance. 
Mosquito females were placed at distances of 1  m and 
never came in direct contact with the treated surface. 
Unfed females of An. gambiae ‘Kisumu’ and An. coluzzii 
from VK3 raised at the insectarium from field-collected 
larvae were used. A total of 60 females were intro-
duced into 4 tubes of 150 ml, with 15 females per tube. 
Mosquito netting was placed at both ends to allow air 
through. Honey-soaked cotton was introduced to ensure 
that females did not die from starvation. The protocol 
followed was the same described by Mosqueira et al. [21], 
except females were exposed for 30 min only, instead of 
12 h. Females were taken to the insectarium for delayed 
mortality assessment after 24  h at 80 ± 10% relative 
humidity and 27 ± 2  °C temperature. Tests were per-
formed from T0 to T4.
Insecticide susceptibility test
The susceptibility test was performed on 2–3  days old 
wild female An. gambiae s.l. using the WHO standard 
vertical tube protocol [28]. Four insecticide-impregnated 
papers were used: permethrin 0.75%, deltamethrin 0.05%, 
fenitrothion 0.1%, and pirimiphos methyl 0.05%. Wild 
An. gambiae s.l. was tested against An. gambiae ‘Kisumu’, 
a fully susceptible reference laboratory strain. Mortality 
controls were carried out by exposing both the Kisumu 
strain and wild populations to non-insecticide-impreg-
nated paper. After 1 h’s exposure, mosquitoes were trans-
ferred into insecticide-free tubes and maintained on 
sucrose solution. Final mortality was recorded 24 h after 
exposure. The threshold of susceptibility was fixed at 95% 
for all active ingredients used [27].
Molecular analysis on resistance
The detection of the L1014F kdr mutation was performed 
following Martinez-Torres et  al. [28] and the ace-1R 
G119S mutation by Weill et al. [29] to analyse the resist-
ance status at the time of the study. Testing took place 
after treatment on An. coluzzii females collected in 2 
arms (control and treated houses) of the study houses.
Statistical analysis
To evaluate efficacy of the insecticide paint, results were 
compiled and analysed using Epi Info Version 6 to test 
for any significant difference in mosquito entry and mor-
tality rates between the different configurations via Chi 
square tests. A 95% confidence interval and a standard 
error were applied respectively to mortality rates and 
mean entries of mosquitoes in houses. When mortal-
ity rates in control houses were between 5 and 20%, 
Abbott’s mortality correction formula was applied [30]. 
Because bioassay tests are subject to variations, a 99% 
confidence interval was applied. The allelic frequency of 
each mutation (kdr and ace-1R) was calculated with the 
formula F(R) = (2RR + RS)/2n where n is the total sam-
ple size. The frequency of kdr and ace-1R in An. coluzzii 
collected in the 2 arms (control and treated) of the study 
houses were compared by Chi square test. The genotypic 
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frequencies at the kdr and ace-1R loci were compared to 
Hardy–Weinberg expectations using the exact test pro-
cedures implemented in GENEPOP (version 4) software 
[31].
Results
Early morning collections (EMCs)
No difference in house attractiveness was found dur-
ing the blank collections. Mosquito collections began 
1 week after the treatment. The maximum mosquitoes 
were collected between the T1 and T2, correspond-
ing to the peak of rainy season, and decreased to be 
fewer than 20 mosquitoes per house at T3 and T4, 
corresponding to the end of the rainy season (Novem-
ber–December). At the end of the experiment, overall 
2624 An. gambiae s.l. were collected with, respectively, 
1,437,772 and 415 for control, paint alone and 
paint + LLIN-treated houses differing significantly 
between control and treated houses (Fig. 2A). No repel-
lent effect was observed between the different treat-
ments in the months, except at T0 where there were 
significantly more mosquitoes collected in control 
houses than treated ones (Fig. 2B).
A sub-sample of 165 mosquitoes (50 ± 10 per arm for 
resistance gene characterization) was molecularly ana-
lysed for species identification within the An. gambiae 
complex, and were all identified as An. coluzzii.
Mortality rates in the houses with paint + LLIN was 
over 80% for 2 months, but decreased progressively, to 
less than 30% at T4. Mortality observed in the control 
houses with no paint ranged from 13 to 8% at T3 and 
T4 (Table 1).
Residual efficacy tests using 30‑min WHO bioassays
The mortality rates obtained after the 30-min stand-
ard WHO cone bioassays with An. gambiae ‘Kisumu’ 
reached 100% on all treated surfaces (metallic windows 
and doors) during the first 3 months after paint appli-
cation (T0–T2). From the painted doors (Table 2A), the 
residual efficacy was still superior to 80% (85%) in T3 
but fell to 78% at T4. With painted windows, the mor-
tality rates were relatively higher and rates reached 80% 
at T4 (Table 2A).
The mortality rates obtained with the local An. 
coluzzii from VK3 were between 100 and 90% from T0 
to T2 and decreased significantly under 80% to reach 39 
and 53%, respectively, for painted doors and windows 
at T3. At T4, tests were not performed with An. coluzzii 
from VK3 due to the scarcity of the local mosquito 
population (Table 2B).
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Fig. 2 Number of Anopheles gambiae s.l. collected from early 
morning collections. A Total number of Anopheles gambiae s.l. 
collected per arm; B mean number monthly collected per house for 
each configuration. Letters above bars indicate significant differences 
between treatment arms. LLINs long‑lasting insecticide‑treated nets; T 
time in months since treatment
Table 1 Mortality rates on local populations of Anopheles coluzzii using early morning collection
Averages taken for each configuration, 10 houses per configuration
IP Insecticide paint only; LLINs long-lasting insecticide-treated nets; T time in months since treatment; EMCs early morning collections. Numbers in the same column 
sharing a letter superscript do not differ significantly (P > 0.05)
% Mortality in Anopheles coluzzii collected 
via EMCs ± CI 95%
T0 T1 T2 T3 T4
Control (LLINs and/or other methods) 0 0 0 13 ± 6.6a 8 ± 17.2a
IP/1 layer on doors and windows 100b 68 ± 6.4b 58.5 ± 4.6b 34 ± 12.3b 7.57 ± 23.2a
IP/1 layer on doors and windows + new LLINs 100b 81.1 ± 6.2b 60.6 ± 7.3b 39.4 ± 16.8b 28.3 ± 45.5a
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Spatial mortality assessments
In the control houses (windows and doors without any 
treatment), the mortality rates recorded were very low 
with less than 5% both for An. gambiae ‘Kisumu’ and 
An. coluzzii VK3. From T0 to T1, the distant killing 
effect went from 90 to 75% against An. gambiae ‘Kisumu’ 
placed for 30 min at 1 m from the painted doors and win-
dows. At T2, this mortality decreased to 30%. By T3 and 
T4, mortality further decreased to 20% (Table 3A).
In the case of An. coluzzii at T0, 80% were killed. By 
T1, 77% of exposed individuals were killed. By T2, spa-
tial mortality decreased to 25%, and by T3 to 15%. Tests 
were not performed with An. coluzzii at T4 for the same 
reason as for the residual efficacy tests given above 
(Table 3B).
Resistance status and allelic frequency of the mutations 
kdr L1014F and ace‑1R
The resistance status of wild populations of An. coluzzii 
showed that they were resistant to pyrethroids (perme-
thrin 0.75% and deltamethrin 0.05%) with mortality rates 
less than 65%. They were fully susceptible to OPs (feni-
trothion 0.1% and pirimiphos methyl 0.05%) with 100% 
of mortalities (Fig. 3). The allelic frequency of the L1014F 
kdr mutation in An. coluzzii females collected during 
EMCs at VK3 was high, averaging 94% (Table 4) without 
any difference between control and treated houses at the 
time of the study.
Within specimens analysed by PCR, no individual was 
detected sharing the ace-1R mutation, as well as from 
mosquitoes collected in control and paint treated houses 
(Table 4).
Discussion
At the VK3 village, the strategy consisted of a combina-
tion of LLINs and Inesfly 5A IGR™ applied to windows 
and doors. The study design reached the experimental 
proof concept for malaria prevention developed in “the 
mosquito malaria theory” [32]. The concept was recently 
reviewed in order to assess the hypothesis that improved 
Table 2 Residual efficacy tests
Averages taken for each configuration, 10 houses per configuration
IP Insecticide Paint; LLINs long-lasting insecticide-treated nets; T time in months since treatment; ND not done because of insufficient numbers reared in the 
insectarium. Numbers in the same column sharing a letter superscript do not differ significantly (P > 0.05)
% Mortality using WHO test cones ± CI 99% Anopheles gambiae Kisumu (A) Anopheles coluzzii VK3 (B)
T0 T1 T2 T3 T4 T0 T1 T2 T3 T4
Control (LLINs and/or other methods such as coils) 5 ± 2.4a 5 ± 2.4a 3 ± 1.9a 10 ± 3.3a 7 ± 2.8a 8 ± 3.1a 7 ± 2.8a 2 ± 1.5a 2 ± 1.5a ND
IP/1 layer on doors + new LLINs 100b 100b 100b 85 ± 4.1b 78.5 ± 4.6b 100b 100b 90 ± 3.3b 39 ± 5.5b ND
IP/1 layer on windows + new LLINs 100b 100b 100b 95 ± 3.1b 82 ± 5.3b 100b 100b 90 ± 4.1b 53 ± 6.9b ND
Table 3 Spatial mortality assessments on VK3 mosquitoes
Averages taken for each configuration, 10 houses per configuration
IP Insecticide paint; LLINs long-lasting insecticide-treated nets; T time in months since treatment; ND not done because of insufficient numbers reared in the 
insectarium. Numbers in the same column sharing a letter superscript do not differ significantly (P > 0.05)
% Mortality during spatial mortality 
assessments ± CI 99%
Anopheles gambiae Kisumu (A) Anopheles coluzzii VK3 (B)
T0 T1 T2 T3 T4 T0 T1 T2 T3 T4
Control (LLINs and/or other methods) 2 ± 2.7a 2.9 ± 3.2a 1.1 ± 2.1a 3.6 ± 3.6a 3.9 ± 3.7a 1.7 ± 2.5a 2.6 ± 3.1a 2.9 ± 3.2a 2.1 ± 2.8a ND
IP/1 layer on doors and windows + LLINs 90 ± 5.8b 75 ± 8.4b 30 ± 8.9a 20 ± 7.8a 20 ± 7.8a 80 ± 7.8b 77 ± 8.2b 25 ± 8.4a 15 ± 6.9a ND
Fen 0.1% 
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Fig. 3 Insecticide susceptibility. Mortality rates of wild female 
Anopheles coluzzii populations and female Anopheles gambiae Kisumu 
using the WHO standard tube protocol. Fen 0.1% fenithrotion 0.1%; 
Pirimip 0.05% pirimiphos methyl 0.05%; Delta 0.05% deltamethrin 
0.05%; Perm 0.75% permethrin 0.75%
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housing can reduce malaria by decreasing entry of mos-
quitoes [33]. More particularly, a randomized controlled 
trial in The Gambia showed that the use of window 
screens and closed eaves led to a reduction in the num-
ber of mosquitoes entering houses, and a reduction in the 
prevalence of anaemia in children, but it did not show a 
reduction in malaria prevalence [34]. Other studies have 
shown that the closure of eaves and netting over windows 
can be effective in preventing mosquito entry into houses 
[35, 36]. However, there is little evidence that screening 
can reduce malaria infection.
In the VK3 study, the insecticide paint applied on win-
dows and doors did not necessarily prevent the entry of 
mosquitoes, probably due to the effects of Ops, which do 
not have repellent characteristics [19]. However, there 
was a significant reduction in the numbers of mosqui-
toes collected in treated houses, especially into those 
supplied with new LLINs, compared to the control. 
This was probably due to the repellent effect of the del-
tamethrin, a pyrethroid contained in LLINs used in this 
study. The number of dead mosquitoes collected during 
EMCs was always higher in houses supplied with new 
LLINs, suggesting that the treatment of windows and 
doors combined with new LLINs yielded a high level 
of killing efficacy compared to control houses, but the 
effect lasted for only about 2  months. The Insecticide 
Paint Inesfly had been tested in past studies yielding a 
long-term mortality rate of 80% over 12  months when 
applied on the walls against An. coluzzii, the local pyre-
throid-resistant population [20, 22]. The reason for this 
short-lasting efficacy obtained in the present study may 
be that the size of the treated surface was insufficient to 
ensure a sustained protection beyond 2  months. This is 
consistent with repeated observations on the importance 
of having a volume effect [20–22]. Another possibility is 
the degradation that insecticides may undergo, despite 
microencapsulation, when exposed to high levels of heat 
and sunlight [11]. This is especially the case with metallic 
doors and windows. The temporal efficacy of this kind 
of treatment could be improved beyond 3  months by 
increasing the treatment dose with two layers of 1  kg/6 
sq m instead of one layer of 1 kg/6 sq m, or repeating the 
treatment of a layer of 1 kg/6 sq m 2 months later. This 
needs to be tested.
The mortality rates in control houses in VK3 without 
insecticide paint were observed in T3 and T4 only, cor-
responding to October and November, during which 
the National Malaria Control Programme (NMCP) had 
organized a mass distribution of new LLINS at VK3 
through a universal coverage campaign. The acquisition 
and use of new LLINs contributed to the low mortality 
observed in control houses.
These results are consistent with recent studies in 
nearby VK1 and VK7 villages [22, 9], with mortality rates 
in houses with LLINs (PermaNet 2.0) only, similar to the 
observed rates in the present study.
Given the high killing effect of the insecticide paint 
against OP-susceptible mosquitoes and that this study 
was not carried out under controlled conditions, it was 
difficult to reliably assess the pyriproxyfen efficacy. 
Effect of the pyriproxyfen into this formulation could be 
assessed against OP-resistant mosquito populations in 
controlled conditions [19]. This allows the female mos-
quitoes to be sufficiently in contact with the insecticide 
and still live, making it possible to evaluate the effect of 
the IGR by monitoring their life history trait. Moreover, 
breeding sites close to experiment places may be pol-
luted by the pyriproxyfen from Inesfly. The effect may be 
assessed on mosquito larvae.
One potential gain of the combination LLINs/paint 
strategy was the better management of pyrethroid-
resistant mosquitoes, minimizing the risk of resistance 
development for OPs if used alone. Tests showed that 
the allelic frequency of the L1014F kdr mutation did 
not vary significantly during the testing period. This 
was likely because baseline frequencies are so high 
Table 4 Allelic frequency and genotype of the L1014F kdr and ace-1R mutations in Anopheles coluzzii collected from early 
morning collections
IP Insecticide paint; LLINs long-lasting insecticide-treated nets; EMCs early morning collections; n number of mosquitoes tested; SS sensitive homozygote; RS resistant 
heterozygote; RR resistant homozygote; F (L1014F) allelic frequency of the kdr mutation; F (G119S) allelic frequency of the ace-1R mutation; 95% CI = 95% confidence 
interval, p (HW) value for Hardy–Weinberg equilibrium hypothesis; “–” non-determinable
Treatments Kdr L1014F Ace‑1R (G119S)
n SS RS RR F (L1014F) [95% CI] p (HW) SS RS RR F (G119S) p (HW)
Control (LLINs 
and/or other 
methods)
52 1 3 48 0.952 [0.89–1.01] 0.01 52 0 0 0 –
IP/1 layer on doors 
and win‑
dows + LLINs
49 1 4 44 0.929 [0.86–1.00] <0.05 49 0 0 0 –
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anyway in the area. The L1014S kdr mutation was not 
tested, but it will be monitored in future studies over a 
period of at least 1 year.
With regard to the ace-1R mutation, An. coluzzii 
were considered to be susceptible to OPs as the distri-
bution of the ace-1R mutation is still low thus far (less 
than 10% overall) and in the heterozygous form. These 
results were consistent with the cousin study at VK1 
[22]. Longer term and large data should be obtained 
during the Phase III study.
The killing effect at 1 m from treated surfaces confers 
also the possibility to be used to combat outdoor bit-
ing. Malaria transmission via outdoor biting is not neg-
ligible [37] and the potential of a longer lasting efficacy 
while painting larger external surfaces needs to be eval-
uated. A modified strategy will be tested in large scale 
Phase III to study the effect on malaria incidence in 
children in Burkina Faso but also its incidence on out-
door malaria transmission and nuisance due to other 
culicids. The community-based assays will include 
entomological and clinical assessments as well as soci-
ological questionnaires to assess acceptability by the 
population. Such studies will also provide proper data 
on cost efficacy, which was not clearly addressed in the 
current study.
Conclusions
The application of Inesfly 5A IGR™ in house-proof sys-
tems on windows and doors yielded a long-term killing 
efficacy of about 3  months against pyrethroid-resistant 
malaria vectors. Anopheles coluzzii in the area are highly 
resistant to pyrethroids but susceptible to OPs. The pilot 
study at VK3 showed that treating only windows and 
doors was not efficient in the long term. However, it may 
be a cost- and time-efficient tool during high transmis-
sion peaks. Painting doors and windows, or the interior 
of houses, should be coupled with home improvement 
measures to reduce the permeability of houses to vector 
and pest mosquitoes and other potential disease-trans-
mitting arthropods.
New malaria control tools are needed, but they should 
be in line with current public health efforts and support 
the use of LLINs.
This strategy could be implemented for other vector-
borne diseases, where vectors bite mainly outdoors, such 
as dengue, chikungunya and zika, as well as for nuisance 
caused by indoor and outdoor-biting culicids.
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